<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 24 May 2021 21:42:56 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>郑彪点评 | Science突破：新型CAR-T有效杀伤实体瘤，不伤正常细胞</title><link>https://mp.weixin.qq.com/s/3IDfAXJgrBhfzRYAkTTjJw</link><description></description><content:encoded><![CDATA[郑彪点评 | Science突破：新型CAR-T有效杀伤实体瘤，不伤正常细胞]]></content:encoded><pubDate>Mon, 24 May 2021 21:24:38 +0800</pubDate></item><item><title>脂肪肝新靶点——ABCB10 | Science子刊最新成果</title><link>https://mp.weixin.qq.com/s/1gpl5i1jZRtbkg0w6d9Rxg</link><description></description><content:encoded><![CDATA[脂肪肝新靶点——ABCB10 | Science子刊最新成果]]></content:encoded><pubDate>Sun, 23 May 2021 21:00:54 +0800</pubDate></item><item><title>ASCO2021摘要精选50篇（KRAS抑制剂、Her2 ADC、TROP2 ADC……）</title><link>https://mp.weixin.qq.com/s/G6KNXF-PilLkkXP0_8O_Rg</link><description></description><content:encoded><![CDATA[ASCO2021摘要精选50篇（KRAS抑制剂、Her2 ADC、TROP2 ADC……）]]></content:encoded><pubDate>Sat, 22 May 2021 20:58:34 +0800</pubDate></item><item><title>抗抑郁70年老药，还能抗癌？MOA抑制剂“搭档”PD-1抗体，大大提升抗肿瘤疗效 | Science子刊</title><link>https://mp.weixin.qq.com/s/PN9XwoOceRkhgLvbQ5L32Q</link><description></description><content:encoded><![CDATA[抗抑郁70年老药，还能抗癌？MOA抑制剂“搭档”PD-1抗体，大大提升抗肿瘤疗效 | Science子刊]]></content:encoded><pubDate>Fri, 21 May 2021 20:58:17 +0800</pubDate></item><item><title>让肿瘤自产抗体“自杀”！PNAS报道新型腺病毒递送系统：瘤内抗体水平比直接给药提高21倍</title><link>https://mp.weixin.qq.com/s/aLeugqar9AW03MAPhmmp5w</link><description></description><content:encoded><![CDATA[让肿瘤自产抗体“自杀”！PNAS报道新型腺病毒递送系统：瘤内抗体水平比直接给药提高21倍]]></content:encoded><pubDate>Thu, 20 May 2021 21:01:46 +0800</pubDate></item><item><title>新型PROTAC来了：SPNpro，究竟是何技术？</title><link>https://mp.weixin.qq.com/s/ZpyCBA4_rdQdjb9DDWxX-w</link><description></description><content:encoded><![CDATA[新型PROTAC来了：SPNpro，究竟是何技术？]]></content:encoded><pubDate>Wed, 19 May 2021 21:06:03 +0800</pubDate></item><item><title>Nature：中国上市肿瘤新药的加速路径分析</title><link>https://mp.weixin.qq.com/s/0EZ0Dng2tyDkAsBylLeDHA</link><description></description><content:encoded><![CDATA[Nature：中国上市肿瘤新药的加速路径分析]]></content:encoded><pubDate>Tue, 18 May 2021 20:58:33 +0800</pubDate></item><item><title>一箭双雕！胰腺癌新靶点SLC7A11：突破胰腺癌防御堡垒“潜力军”</title><link>https://mp.weixin.qq.com/s/dnGqOYTLyraBYTr_KC4zbA</link><description></description><content:encoded><![CDATA[一箭双雕！胰腺癌新靶点SLC7A11：突破胰腺癌防御堡垒“潜力军”]]></content:encoded><pubDate>Mon, 17 May 2021 20:58:45 +0800</pubDate></item><item><title>一马当先的可溶性配体：炎症性肠病治疗靶点概览</title><link>https://mp.weixin.qq.com/s/fvXM3CEWIRu5YvUJ4NKcLA</link><description></description><content:encoded><![CDATA[一马当先的可溶性配体：炎症性肠病治疗靶点概览]]></content:encoded><pubDate>Sun, 16 May 2021 20:58:49 +0800</pubDate></item><item><title>以毒抗菌！噬菌体疗法公司完成4075万美元B轮融资，有望突破抗生素耐药困境</title><link>https://mp.weixin.qq.com/s/SWtTXMA6662C9B0yF3Hf8w</link><description></description><content:encoded><![CDATA[以毒抗菌！噬菌体疗法公司完成4075万美元B轮融资，有望突破抗生素耐药困境]]></content:encoded><pubDate>Sat, 15 May 2021 20:58:56 +0800</pubDate></item><item><title>细胞治疗与智能制造融合创新高峰论坛在宁举办</title><link>https://mp.weixin.qq.com/s/Qewzb3PtdSibbIBk9caNBg</link><description></description><content:encoded><![CDATA[细胞治疗与智能制造融合创新高峰论坛在宁举办]]></content:encoded><pubDate>Sat, 15 May 2021 20:58:56 +0800</pubDate></item></channel></rss>